Clinical Trials Browser

Interventional × Peritoneal Neoplasms × avelumab × Clear all

NCT03252938 2026-02-19

INSIGHT

Phase 1 Active not recruiting

GenitourinaryGynecologic

Carcinoma, Transitional Cell, Peritoneal Neoplasms